Redeye: Calliditas Therapeutics: Scores a record deal in China

In this research update, we dig deeper into the Greater China deal and provide you with a brief update on the competitive landscape within IgA Nephropathy.

Read more and download the analysis: http://bit.ly/2Fdu46W

Start following companies at Redeye to recieve the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/